FLOMENBERG NEAL (Chief Scientific Officer) sold 20.2% of their position (1.08M shares) of TEVOGEN BIO HOLDINGS INC. on the open market
Open‑market sale worth $1.75M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/18/2024ACC: 0001062993-24-017785
Officer· Chief Scientific Officer
Since Feb 2024
-1.08M
Net shares
Net seller
$1.75M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.08M disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.08M
Price / share
$1.62
Trade value
$1.75M
% of position
20.2%
10/17/2024
5.33M→4.25M
Total
Net shares
−1.08M
Net value
-$1.75M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/17/2024 | S · Sale | −1.08M | $1.62 | $1.75M | 20.2% | 5.33M | 4.25M |
| Total | −1.08M | -$1.75M | ||||||
Derivative Transactions0
No derivative transactions reported